Pan-cancer bioinformatic analysis revealed that higher LTB4R expression was associated with poor relapse-free survival (RFS), poor OS, and poor distant metastasis-free survival (DMFS) in breast cancer datasets without segregation into molecular subtypes [33]. Here, LTB4R is linked to cancer.